Draft Guidance for Industry: Safety of Nanomaterials in Cosmetic Products; Availability, 24722 [2012-9934]
Download as PDF
24722
Federal Register / Vol. 77, No. 80 / Wednesday, April 25, 2012 / Notices
FDA/Government/Students.2 There will
also be a 1-day rate of $425 for OCRA
members and $475 for non-members.
The registration fee will cover actual
expenses, including refreshments,
lunch, materials, parking, and speaker
expenses.
If you need special accommodations
due to a disability, please contact Linda
Hartley (see Contact) at least 10 days
before the conference.
Dated: April 20, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–9968 Filed 4–24–12; 8:45 am]
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments on the draft guidance to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Kapal Dewan, Center for Food Safety
and Applied Nutrition (HFS–125), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740,
240–402–1130.
SUPPLEMENTARY INFORMATION:
BILLING CODE 4160–01–P
I. Background
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–D–0489]
Draft Guidance for Industry: Safety of
Nanomaterials in Cosmetic Products;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the draft guidance
entitled ‘‘Guidance for Industry: Safety
of Nanomaterials in Cosmetic
Products.’’ The draft guidance, when
finalized, will represent FDA’s current
thinking on the safety assessment of
nanomaterials in cosmetic products.
This guidance is intended to assist
industry in identifying the potential
safety issues of nanomaterials in
cosmetic products and developing a
framework for evaluating them.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by July 24, 2012.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Office of Cosmetics and Colors, Center
for Food Safety and Applied Nutrition
(HFS–100), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740. Send
two self-addressed adhesive labels to
assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance.
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
2 See
footnote 1.
VerDate Mar<15>2010
15:14 Apr 24, 2012
Jkt 226001
FDA is announcing the availability of
the draft guidance entitled ‘‘Guidance
for Industry: Safety of Nanomaterials in
Cosmetic Products.’’ The draft guidance
is intended to assist industry in
identifying the potential safety issues of
nanomaterials in cosmetic products and
developing a framework for evaluating
these issues.
The draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the Agency’s current thinking
on the safety of nanomaterials in
cosmetic products. It does not create or
confer any rights for or on any person
and does not operate to bind FDA or the
public. An alternative approach may be
used if such approach satisfies the
requirements of the applicable statutes
and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at either
https://www.fda.gov/CosmeticGuidances
or https://www.regulations.gov. Always
access an FDA guidance document by
using FDA’s Web site listed previously
to find the most current version of the
guidance.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Dated: April 17, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–9934 Filed 4–24–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–D–0490]
Draft Guidance for Industry: Assessing
the Effects of Significant
Manufacturing Process Changes,
Including Emerging Technologies, on
the Safety and Regulatory Status of
Food Ingredients and Food Contact
Substances, Including Food
Ingredients That Are Color Additives;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance entitled
‘‘Guidance for Industry: Assessing the
Effects of Significant Manufacturing
Process Changes, Including Emerging
Technologies, on the Safety and
Regulatory Status of Food Ingredients
and Food Contact Substances, Including
Food Ingredients That Are Color
Additives.’’ The draft guidance, when
finalized, will explain FDA’s current
thinking on the factors to be considered
when determining whether changes in
manufacturing process, including the
intentional reduction in particle size to
the nanoscale, for a food substance
already in the market affects the safety
and regulatory status of the food
substance, and whether a new
regulatory submission to FDA is
warranted.
SUMMARY:
Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either written or electronic comments
on the draft guidance by July 24, 2012.
ADDRESSES: Submit written requests for
single copies of the draft guidance
entitled ‘‘Guidance for Industry:
Assessing the Effects of Significant
Manufacturing Process Changes,
Including Emerging Technologies, on
the Safety and Regulatory Status of Food
Ingredients and Food Contact
Substances, Including Food Ingredients
That Are Color Additives’’ to the Office
of Food Additive Safety (HFS–200),
DATES:
E:\FR\FM\25APN1.SGM
25APN1
Agencies
[Federal Register Volume 77, Number 80 (Wednesday, April 25, 2012)]
[Notices]
[Page 24722]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-D-0489]
Draft Guidance for Industry: Safety of Nanomaterials in Cosmetic
Products; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of the draft guidance entitled ``Guidance for Industry:
Safety of Nanomaterials in Cosmetic Products.'' The draft guidance,
when finalized, will represent FDA's current thinking on the safety
assessment of nanomaterials in cosmetic products. This guidance is
intended to assist industry in identifying the potential safety issues
of nanomaterials in cosmetic products and developing a framework for
evaluating them.
DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by July 24, 2012.
ADDRESSES: Submit written requests for single copies of the draft
guidance to the Office of Cosmetics and Colors, Center for Food Safety
and Applied Nutrition (HFS-100), Food and Drug Administration, 5100
Paint Branch Pkwy., College Park, MD 20740. Send two self-addressed
adhesive labels to assist that office in processing your request. See
the SUPPLEMENTARY INFORMATION section for electronic access to the
draft guidance.
Submit electronic comments on the draft guidance to https://www.regulations.gov. Submit written comments on the draft guidance to
the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kapal Dewan, Center for Food Safety
and Applied Nutrition (HFS-125), Food and Drug Administration, 5100
Paint Branch Pkwy., College Park, MD 20740, 240-402-1130.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of the draft guidance entitled
``Guidance for Industry: Safety of Nanomaterials in Cosmetic
Products.'' The draft guidance is intended to assist industry in
identifying the potential safety issues of nanomaterials in cosmetic
products and developing a framework for evaluating these issues.
The draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the Agency's current thinking on the safety
of nanomaterials in cosmetic products. It does not create or confer any
rights for or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such approach satisfies
the requirements of the applicable statutes and regulations.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. It is no
longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet may obtain the draft guidance
at either https://www.fda.gov/CosmeticGuidances or https://www.regulations.gov. Always access an FDA guidance document by using
FDA's Web site listed previously to find the most current version of
the guidance.
Dated: April 17, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-9934 Filed 4-24-12; 8:45 am]
BILLING CODE 4160-01-P